Calidi Biotherapeutics, Inc.

CLDI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
S-1/A Apr 2, 2024
8-K Apr 1, 2024
S-1/A Apr 1, 2024
D Mar 21, 2024
D Mar 21, 2024
D Mar 21, 2024
D Mar 21, 2024
D Mar 21, 2024
8-K Mar 18, 2024
10-K Mar 15, 2024
3 Mar 12, 2024
424B3 Mar 12, 2024
8-K Mar 12, 2024
424B3 Mar 1, 2024
8-K Mar 1, 2024
8-K Feb 28, 2024
SC 13G/A Feb 14, 2024 683 CAPITAL MANAGEMENT, LLC
SC 13G/A Feb 14, 2024 SC 13G/A
SC 13G/A Feb 12, 2024
SC 13G/A Feb 12, 2024 CALIDI BIOTHERAPEUTICS, INC.
424B3 Feb 12, 2024
8-K Feb 12, 2024
SC 13G/A Feb 9, 2024 SC 13G/A
SC 13G/A Feb 9, 2024 CALIDI BIOTHERAPEUTICS INC 13GA
8-K Feb 7, 2024
← Newer Page 9 of 17 · 403 filings Older →